Research criteria for the diagnosis of prodromal dementia with Lewy bodies
Cleveland Clinic · University of Miami · +6 more institutions
Abstract
The prodromal phase of dementia with Lewy bodies (DLB) includes (1) mild cognitive impairment (MCI), (2) delirium-onset, and (3) psychiatric-onset presentations. The purpose of our review is to determine whether there is sufficient information yet available to justify development of diagnostic criteria for each of these. Our goal is to achieve evidence-based recommendations for the recognition of DLB at a predementia, symptomatic stage. We propose operationalized diagnostic criteria for probable and possible mild cognitive impairment with Lewy bodies, which are intended for use in research settings pending validation for use in clinical practice. They are compatible with current criteria for other prodromal…
Citation impact
- FWCI
- 54.12
- Percentile
- 100%
- References
- 63
Authors
31- IGIan G. McKeithCorresponding
Cleveland Clinic, University of Miami, Jacksonville College, University of California System, Weinberg Medical Physics (United States), Mayo Clinic in Florida, Fondazione IRCCS Istituto Neurologico Carlo Besta, Nagoya University
- TJTanis J. Ferman
Cleveland Clinic, University of Miami, Jacksonville College, University of California System, Weinberg Medical Physics (United States), Mayo Clinic in Florida, Fondazione IRCCS Istituto Neurologico Carlo Besta, Nagoya University
- ATAlan Thomas
Cleveland Clinic, University of Miami, Jacksonville College, University of California System, Weinberg Medical Physics (United States), Mayo Clinic in Florida, Fondazione IRCCS Istituto Neurologico Carlo Besta, Nagoya University
- FBFrédéric Blanc
Mayo Clinic in Florida
- BFBradley F. Boeve
Cleveland Clinic, University of Miami, Jacksonville College, University of California System, Weinberg Medical Physics (United States), Mayo Clinic in Florida, Fondazione IRCCS Istituto Neurologico Carlo Besta, Nagoya University
Topics & keywords
- Dementia with Lewy bodies
- Delirium
- Dementia
- Psychiatry
- Prodromal Stage
- Disease
- Psychology
- Operationalization
- Good health and well-being
Funding
- UDU.S. Department of DefenseAward: CDMRP/W81XW1810516
- MJMichael J. Fox Foundation for Parkinson's Research
- ELEli Lilly and CompanyAward: P50 AG005134
- AAstraZeneca
- SSanofi
- BBiogen
- CFCHDI Foundation
- TPTeva Pharmaceutical Industries
- SSunovion
- WTWellcome Trust
- LFLittle Family Foundation
- DDemensförbundet
- JPJazz Pharmaceuticals
- PFParkinson's Foundation
- IPIonis Pharmaceuticals
- APACADIA Pharmaceuticals
- PProthena
- ASAlzheimer's Society
- LBLewy Body Dementia AssociationAwards: R01 AG057681, U01 NS100610
- VTVoyager Therapeutics
- TPTauRx Pharmaceuticals
- NINational Institute for Health and Care Research
- RSRoyal Society
- NUNewcastle University
- ECEuropean Commission
- WFWolfson Foundation
- MDMinistero della SaluteAward: NET-2011-02346784
- EEisai
- NUNewcastle upon Tyne Hospitals NHS Foundation Trust
- PCParkinson Canada
- HLH. Lundbeck A/S
- NINational Institutes of HealthAwards: UL1TR001873, AGO5131, P50-AG16574, NS100620, U01AG016976, P30AG062429, U01AG023749, R01 AG054551, NS073671, P30AG062421, U01AG051412, U19AG024904, R01 AG040211, U01 NS100610, P50 AG005134, AG005134, U01AG045390, U01-NS100620, NIH P50, AG062677, P30-AG062677, P50AG008702, AG16574, R01 AG057681
- GGenentech
- PParkinsonfonden
- ARAvid Radiopharmaceuticals
- CICanadian Institutes of Health ResearchAward: MOP13129
- MRMedical Research Council
- EAEconomic and Social Research Council
- NHNational Health and Medical Research Council
- NNNIHR Newcastle Biomedical Research Centre
- NCNIHR Cambridge Biomedical Research Centre
- NINational Institute on AgingAwards: U01AG051412, AG005134, R01 AG057681, P30AG062429, AGO5131, P30AG062421, U01AG045390, P50AG008702, U01AG023749, U19AG024904, P50 AG005134, U01AG016976, UL1TR001873, P50-AG16574, R01 AG040211, AG16574
- NINational Institute of Neurological Disorders and StrokeAwards: NS100620, UO1 NS100610, NS073671, U01NS100600, P50 AG005134
- CDCongressionally Directed Medical Research Programs